Beijing, China

Boling Xu

This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Research Institute of Materia Medica Chinese Acadamy of Medical Sciences. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boling Xu. Retrieved from https://idiyas.com/inventor/boling-xu-smt2ei5p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Boling Xu: Innovator in Sulfonyl-Containing Compounds

Introduction

Boling Xu is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on sulfonyl-containing compounds.

Latest Patents

Boling Xu holds a patent for "Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof." This invention relates to sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones compounds characterized by a specific formula. The compounds have various applications in medicine, showcasing their potential therapeutic benefits.

Career Highlights

Throughout his career, Boling Xu has worked with prominent organizations, including Jiangsu Hengrui Medicine Company Ltd. and the Research Institute of Materia Medica at the Chinese Academy of Medical Sciences. His experience in these institutions has allowed him to advance his research and contribute to the development of new medicinal compounds.

Collaborations

Boling Xu has collaborated with esteemed colleagues, including Guifang Cheng and Wen Hui Hu. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Boling Xu's work in the development of sulfonyl-containing compounds highlights his role as a significant inventor in the field of medicinal chemistry. His contributions continue to influence the landscape of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…